Biofrontera Inc. (NASDAQ:BFRI) Q4 2025 Earnings Call Transcript March 19, 2026 Biofrontera Inc. beats earnings expectations. Reported EPS is $0.5, expectations were $0.195. Operator: Welcome to the ...

Need a quote from a Motley Fool analyst? The risks and uncertainties associated with the company's business are detailed in ...

Positive topline results in open-label Phase 3 trial evaluating the long-term safety of denifanstat in patients with moderate to severe acne in China reported by Ascletis China’s National Medical ...

Detailed price information for Biofrontera Inc (BFRI-Q) from The Globe and Mail including charting and trades.

"We are thrilled to reach this crucial milestone in our clinical program”, said Dr. Hermann Luebbert, CEO and Chairman of ...

Understanding the Testosterone-Acne Connection If you thought acne breakouts were only a teenage problem, think again.

Acne is one of the most common skin concerns, especially among teenagers and young adults. While pimples may eventually heal, they often leave behind visible marks on the skin. Many people assume ...

New data specific to patients with skin of color expands evidence supporting strong efficacy and safety for clascosterone ...

The future of acne treatment might look a whole lot different than the range of oral and topical medications currently on pharmacy shelves. Previous attempts to use nano-scale delivery drivers to ...

Almirall, S.A. (ALM)a global pharmaceutical company dedicated to medical dermatology announced today that China’s National Medical Products Administration (NMPA) has approved Seysara® (sarecycline ...

I've always been someone who gets the occasional pre-period breakout, but after having a baby two years ago, postpartum hormones brought all acne hell on my face. I had red, painful cysts on my chin ...

Denifanstat at doses of 25 mg, 50 mg, and 75 mg significantly improved lesion counts in patients with moderate to severe acne vulgaris when compared with placebo. Once-daily oral denifanstat improved ...